Pfizer Urges India To Take Firm Stand on Data Exclusivity, Patents

Law360, New York (October 12, 2003, 12:00 AM EDT) -- Pfizer's Indian subsidiary is urging the government to take a "firm and transparent" stand on issues such as data exclusivity and product patents, the Financial Express reported.

The Indian government was required by TRIPS, the World Trade Organization's Intellectual Property Agreement, to provide data protection by 2000. Data exclusivity and product patents have to be enacted before the end of next year. However, Pfizer claims that local pharmaceutical companies are pressuring the government to slow implementation on data exclusivity, undermining clinical research and new-product registrations....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.